Changes in IL-18 Level in Response to Metformin Treatment in Iraqi Women with Poly Cystic Ovarian Syndrome (Placebo Controlled Study)
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
www.ijsr.net | Open Access | Fully Refereed | Peer Reviewed International Journal

ISSN: 2319-7064

Research Paper | Medicine Science | Iraq | Volume 6 Issue 4, April 2017

Changes in IL-18 Level in Response to Metformin Treatment in Iraqi Women with Poly Cystic Ovarian Syndrome (Placebo Controlled Study)

Huda I. Al-Qadhi, Tharwa H. Hassan Al-Tai, Shoub Yassin Hussein

Background The most common endocrine disorder affect women between the ages of 18 and 44 is PCOS. ovaries stimulated by high level of luteinizing hormone ( LH) from the anterior pituitary gland or by excessive insulin (hyperinsulinaemia). A majority of women with PCOS have insulin resistance. IL-18 play a role in some inflammatory conditions. [17] In women PCOS, serum IL 18 is increased and there is a strong association with increased insulin resistance.Metformin is a drug used in type 2 diabetes. It acts by reducing glucose synthesis by the liver and increasing insulin sensitivity to enhance peripheral glucose uptake to reduce. In PCOS it is used to reduce insulin resistance and improve ovarian function. Aim of the work To find changes in IL 18 level in response to metformine treatment. Patients and methods Double blind placebo controlled study carried from November 2016 to February 2017 in which 50 patients blindly assigned into two groups by codes placebo and treatment group. recieving 850mg once daily of starch and metformin successively for three months. Body mass index, hormonal profile and serum IL18 was measured at baseline and at the end of the study. Results At the end of study the code was opened and 30 patient was in the treatment group while 20 patients in the placebo group. all measures was compared between baseline and at the end of the study. mean level of IL-18 was (312.1199.164 ) before metformin treatment in the placebo group and (306.200.186.989) in the treatment group. At the end of the study there was marked decrease (106.6699.281) in the treatment group with statistically significant change in the treatment group but not in the placebo group (341.33102.996).also there was significant difference between placebo and treatment group at the end of the study. Conclusion metformin in addition to its role as insulin sensitizer it also reduces inflammation in PCOS patients marked by significant reduction of S.IL 18.

Keywords: Metformin, IL18, PCOS

Edition: Volume 6 Issue 4, April 2017

Pages: 1653 - 1656

Share this Article

How to Cite this Article?

Huda I. Al-Qadhi, Tharwa H. Hassan Al-Tai, Shoub Yassin Hussein, "Changes in IL-18 Level in Response to Metformin Treatment in Iraqi Women with Poly Cystic Ovarian Syndrome (Placebo Controlled Study)", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20172467, Volume 6 Issue 4, April 2017, 1653 - 1656

133 PDF Views | 102 PDF Downloads

Download Article PDF



Similar Articles with Keyword 'Metformin'

Research Paper, Medicine Science, Iraq, Volume 6 Issue 4, April 2017

Pages: 1653 - 1656

Changes in IL-18 Level in Response to Metformin Treatment in Iraqi Women with Poly Cystic Ovarian Syndrome (Placebo Controlled Study)

Huda I. Al-Qadhi, Tharwa H. Hassan Al-Tai, Shoub Yassin Hussein

Share this Article

Research Paper, Medicine Science, India, Volume 4 Issue 2, February 2015

Pages: 783 - 786

Estimation of Vitamin B12 and Vitamin D Levels in Patients of Type-2 Diabetes Mellitus on Metformin Therapy

Mahaboob Fayaz S, Ravikumar Y. S, Manthappa M, Mahesh MG, Aditya Nadella, Sai Vivek V

Share this Article

Review Papers, Medicine Science, Poland, Volume 7 Issue 10, October 2018

Pages: 36 - 39

Adjunctive Treatment in Insulin Therapy in Autoimmune-Mediated Diabetes (Type 1 and Type LADA Diabetes)

Chwalba A, Otto-Buczkowska E

Share this Article

Similar Articles with Keyword 'PCOS'

Research Paper, Medicine Science, United Arab Emirates, Volume 5 Issue 1, January 2016

Pages: 1659 - 1663

An Interventional Study on Effectiveness of Structured Education Programme in Improving the Knowledge of Polycystic Ovarian Syndrome among Female Students of Ras Al Khaimah Medical & Health Sciences University, UAE

Atiqulla Shariff, Gulam Saidunnisa Begum, Ghufran Ayman, Bana Mohammad, Raghad Housam, Noura Khaled

Share this Article

Research Paper, Medicine Science, Iraq, Volume 6 Issue 4, April 2017

Pages: 1653 - 1656

Changes in IL-18 Level in Response to Metformin Treatment in Iraqi Women with Poly Cystic Ovarian Syndrome (Placebo Controlled Study)

Huda I. Al-Qadhi, Tharwa H. Hassan Al-Tai, Shoub Yassin Hussein

Share this Article
Top